NCT03831152View on ClinicalTrials.gov

Extension Study in Primary Distal Renal Tubular Acidosis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 20, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Acidosis, Renal Tubular
Interventions
DRUG

ADV7103

Single group assignment

Trial Locations (1)

33606

University of South Florida Pediatric Infectious Diseases, Tampa

Sponsors

Lead Sponsor

Advicenne Pharma
All Listed Sponsors
lead

Advicenne Pharma

INDUSTRY